Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles

Nanotoxicology

Volumn 10, Issue 3, 2016, Pages 292-302

  Aragao Santiago, Letícia ^a,b   Hillaireau, Hervé ^a,b   Grabowski, Nadège ^a,b   Mura, Simona ^a,b   Nascimento, Thais L ^a,b   Dufort, Sandrine ^c,d   Coll, Jean Luc ^c,d   Tsapis, Nicolas ^a,b   Fattal, Elias ^a,b  

^a UNIV PARIS SUD   (France)

^b CNRS   (France)

^c INSTITUT ALBERT BONNIOT   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Biodegradable; inflammation; lung; nanoparticle

Indexed keywords

CHITOSAN; INTERLEUKIN 6; NANOPARTICLE; POLOXAMER; POLY(LACTIDE CO GLYCOLIDE) BASED NANOPARTICLE; POLYGLACTIN; POLYSTYRENE; POLYVINYL ALCOHOL; TITANIUM DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AEROSOL; AUTACOID; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYSTYRENE DERIVATIVE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; INFLAMMATION; LUNG TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SURFACE CHARGE; ADMINISTRATION AND DOSAGE; AEROSOL; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG LAVAGE; METABOLISM; PATHOLOGY; PHARMACOKINETICS; TISSUE DISTRIBUTION; TOXICITY;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BRONCHOALVEOLAR LAVAGE; CHITOSAN; INFLAMMATION MEDIATORS; LACTIC ACID; LUNG; MICE; NANOPARTICLES; POLOXAMER; POLYGLYCOLIC ACID; POLYSTYRENES; POLYVINYL ALCOHOL; TISSUE DISTRIBUTION; TITANIUM;

EID: 84959499259     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2015.1054908     Document Type: Article

References (24)

1. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77:347-57
2. Bivas-Benita M, Zwier R, Junginger HE, Borchard G. 2005. Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur J Pharm Biopharm 61:214-18
3. Braydich-Stolle LK, Schaeublin NM, Murdock RC, Jiang J, Biswas P, Schlager JJ, Hussain SM. 2009. Crystal structure mediates mode of cell death in TiO2 nanotoxicity. J Nanopart Res 11:1361-74
4. Dailey LA, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M, et al. 2006. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 215:100-8
5. Driscoll KE, Maurer JK. 1991. Cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity. Toxicol Pathol 19:398-405
6. Fattal E, Tsapis N. 2014. Nanomedicine technology: current achievements and new trends. Clin Transl Imaging 2:77-87
7. Gally F, Di YP, Smith SK, Minor MN, Liu Y, Bratton DL, et al. 2011. SPLUNC1 promotes lung innate defense against mycoplasma pneumoniae infection in mice. Am J Pathol 178:2159-67
8. Grabowski N, Hillaireau H, Vergnaud J, Santiago LA, Kerdine-Romer S, Pallardy M, et al. 2013. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. Int J Pharm 454: 686-94
9. Grabowski N, Hillaireau H, Vergnaud-Gauduchon J, Nicolas V, Tsapis N, Kerdine-Römer S, Fattal E. 2016. Surface-modified biodegradable nanoparticles impact on cytotoxicity and inflammation response on a co-culture of lung epithelial cells and human-like macrophages. J Biomed Nanotechnol 12:135-46
10. Hara K, Tsujimoto H, Tsukada Y, Huang CC, Kawashima Y, Tsutsumi M. 2008. Histological examination of PLGA nanospheres for intratracheal drug administration. Int J Pharm 356:267-73
11. Husain M, Saber AT, Guo C, Jacobsen NR, Jensen KA, Yauk CL, et al. 2013. Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. Toxicol Appl Pharm 269: 250-62
12. Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine 4:299-319
13. Maxeiner JH, Karwot R, Hausding M, Sauer KA, Scholtes P, Finotto S. 2007. A method to enable the investigation of murine bronchial immune cells, their cytokines and mediators. Nat Protoc 2:105-12
14. Mohammad A, Amayreh L, Mazzara J, Reineke J. 2013. Rapid lymph accumulation of polystyrene nanoparticles following pulmonary administration. Pharm Res 30:424-34
15. Mura S, Hillaireau H, Nicolas J, Kerdine-Romer S, Le Droumaguet B, Delomenie C, et al. 2011a. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules 12:4136-43
16. Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S, et al. 2011b. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomed 6:2591-605
17. Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-39
18. Oyabu T, Morimoto Y, Hirohashi M, Horie M, Kambara T, Lee B, et al. 2013. Dose-dependent pulmonary response of well-dispersed titanium dioxide nanoparticles following intratracheal instillation. J Nanopart Res 15:1-11
19. Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329-47
20. Reul R, Tsapis N, Hillaireau H, Sancey L, Mura S, Recher M, et al. 2012. Near infrared labeling of PLGA for in vivo imaging of nanoparticles. Polym Chem 3:694-702
21. Saber AT, Jacobsen NR, Mortensen A, Szarek J, Jackson P, Madsen AM, et al. 2012. Nanotitanium dioxide toxicity in mouse lung is reduced in sanding dust from paint. Part Fibre Toxicol 9:4
22. Segel MJ, Aqeilan R, Zilka K, Lorberboum-Galski H, Wallach-Dayan SB, Conner MW, et al. 2005. Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury. Int J Exp Pathol 86:279-88
23. Singh RP, Ramarao P. 2013. Accumulated polymer degradation products as effector molecules in cytotoxicity of polymeric nanoparticles. Toxicol Sci 136:131-43
24. Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, et al. 2012. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J Control Release 157:149-59.